Background: Electrical storm (ES) is a serious problem in patients with an implantable cardioverter defibrillator (ICD). However, insufficient reports have indicated the predictors of ES in ICD patients with idiopathic dilated cardiomyopathy (DCM). The purpose of this study was to clarify the predictors of ES for risk stratification in DCM patients with an ICD.
mplantable cardioverter defibrillators (ICDs) have a high success rate in terminating life-threatening ventricular arrhythmias, including ventricular tachycardia (VT) or ventricular fibrillation (VF), and have become an established therapeutic option for reducing the risk of sudden cardiac death. 1,2 In primary prevention, 21% of patients receive the benefit of ICD with an appropriate therapy within 5 years as shown in the SCD-HeFT trial, 3 whereas in secondary prevention, this is the case for as many as 69-85% patients within 3 years as shown in the AVID trial. 4 However, some patients receive multiple shock therapies in a short period, which is referred to as an electrical storm (ES). 5 Although the incidence of ES is only 4% when ICDs are implanted for primary prevention according to the MADIT II trial, 6 and 10-28% over a 1-to 3-year follow-up period for secondary prevention. 1,7-9
Since there has been an increase in ICD indications, ES has become an important issue because of all the clinical, psychological and economical consequences involved. Although several studies have reported the incidence, predictive factors and clinical prognosis of ES in patients with coronary artery disease, sufficient data does not exist regarding idiopathic dilated cardiomyopathy (DCM). The purpose of this study was to clarify the predictors and prevalence of ES for risk stratification in DCM patients with an ICD.
Methods

Study Population
Among our cohort of 446 ICD patients, 53 consecutive DCM patients (41 men and 12 women, mean age 55±15 years) who received an ICD between 1990 and 2004 at the National
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Cardiovascular Center, Suita, Japan, were included in this study. The following devices were implanted: Medtronic 7217B, 7217D, 7220C, 7221CX, 7223CX, 7227CX, 7229CX, 7271, 7273, 7278 and CPI/Guidant 1600, 1715, 1742, 1790, 1861. We recorded a detailed patient history including any prescriptions and evaluated his/her 12-lead electrocardiogram and transthoracic echocardiogram with doppler screening. The signal-averaged electrocardiogram (SAECG) (Arrhythmia Research Technology model 1200 EPX, Austin, TX, USA) was also examined. This system constituted a vector magnitude with a bidirectional bandpass filter setting of 40-250 Hz combined with the standard bipolar orthogonal (X, Y, Z) leads. Signal averaging of 200-300 beats was performed to obtain a diastolic noise level of <0.5 μV. The onset and offset of the QRS complex were determined by an algorithm that calculated the total QRS duration (TQRSD), root mean square voltage of the last 40 ms of the QRS complex (RMS40) and the duration of the terminal low amplitude signals of <40 μV of the QRS complex (LAS40). Coronary angiography was performed in all patients to rule out ischemic cardiomyopathy. Endocardial biopsy was conducted in 42 patients after obtaining informed consent. The left ventricular ejection fraction (LVEF) was assessed by using radionuclide scanning or left ventriculography. Patients with diffuse left ventricular dysfunction and enlargement of the left ventricle were defined as having DCM when coronary artery disease, valvular disease, or any other cardiomyopathy was excluded.
The study patients received an ICD for secondary prevention of sudden cardiac death after 1 or more episodes of confirmed sustained ventricular tachyarrhythmias or under the context of any presumed tachyarrhythmic syncopal attacks with induction of VT/VF during an electrophysiological study. Single-chamber devices were implanted in 24 (42%) patients and 29 (58%) patients had dual-chamber devices. The ICD was programmed according to the documented or induced arrhythmia with at least 2 detection zones. The lowest VT-detection zone had a cycle length of 419±55 ms. In the VT-zone, anti-tachycardia pacing including more than 1 burst pacing and/or 1 ramp pacing therapy followed by cardioversion were programmed, whereas maximum shocks were programmed in the VF-zone.
Definition of ES and Data Collection
For the purpose of this analysis, we defined ES as the occurrence of at least 3 separate episodes of VT/VF terminated by an ICD intervention within a 24-h period. 8 ICD interventions included antitachycardia pacing, low-energy shocks and high-energy shocks. Repetitive ineffective shocks were not categorized as ES. The follow-up began after the implantation and ended in December 2004. The patients visited the ICD outpatient clinic routinely every 3-6 months and were encouraged to schedule additional visits whenever shocks, palpitations, syncope or pre-syncope had occurred. During each visit, the device was interrogated to evaluate the number and type of episodes with the stored electrograms. In the cases with ES, the patient was admitted to the hospital and blood samples (electrolytes, blood cell count, thyroid, creatinine levels, C-reactive protein, creatinine kinase and troponin), echocardiography and coronary angiography were performed if necessary to investigate the causes.
Statistics
P-values of less than 0.05 were considered statistically significant. The results are expressed as frequencies and percentages for categorical variables and median or mean ± SD for numerical variables. Univariate Cox proportional hazards models were used to assess the significance of baseline variables with respect to the outcome. Parameters with P<0.10 by univariate analysis were included in a Cox proportional hazards multivariate regression analysis and then adjusted for age, sex, left ventricular diastolic diameter (LVDd) and LVEF. The relationship between the clinical predictors and the occurrence of ES were analyzed by means of survival analysis techniques. The survival function was computed as the time of the implantation to the occurrence of ES. The observation was censored at the time of the last known follow-up or time of death, when ES did not occur. Eventfree survival curves were calculated according to the Kaplan-Meier method. The relationship between the occurrence of ES and the prognosis was similarly analyzed. A log rank test was used to determine whether significant differences existed between the curves. A statistical analysis was performed using JMP 5.1 software. TAKIGAWA M et al. Figure 1 . The cumulative probability of survival for dilated cardiomyopathy patients with electrical storm (ES) and those without ES. There was a significant difference in survival between the 2 groups (P<0.0001). ICD, implantable cardioverter defibrillator. Table 1 .
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Results
Baseline Characteristics
The baseline characteristics of the 53 consecutive DCM patients are outlined in Table 1 . All patients received ICD as a secondary prevention. At the time of implantation, the patients were 55±15 years old. They had a mean LVEF of 27% (9-50%) and a mean LVDd of 67 mm (52-94 mm). The mean NYHA class at the time of the ICD implantation was 1.8±0.8 and the creatinine clearance was 74±29 ml/min. Seventeen (32%) patients had a history of atrial fibrillation (AF). Before ICD implantation, spontaneous VTs were documented in 35 (66%) patients and VF in the remaining 20 (34%) as index arrhythmias. Inappropriate shock therapies were observed in 14 (26%) patients due to sinus tachycardia in 8 (15%) patients, AF in 4 (7.5%) patients and other reasons in 2 (3.5%) patients. As for the medications, β-blockers were prescribed in 43 (81%) patients and amiodarone in 27 (56%).
ES
During a mean follow-up of 52±34 months (median 46 months, range 2-158 months), a total of 18 (34%) patients experienced at least 1 ES episode (median 2 ES episodes per patient). Eleven (61%) patients of the 18 patients with ES experienced 2 or more ES episodes. In 5 (27%) patients, ES was the first episode of an appropriate ICD therapy. The mean duration between the first ES occurrence and ICD implantation was 24±31 months. Three (17%) patients had an exacerbation of their heart failure and the other patients had "extrinsic" causes: 3 (17%) patients had diarrhea or a low potassium level, 2 had an infection and 1 had discontinued the drug therapy. However, no clinical cause could be identified in 9 (50%) patients. Figure 1 shows the cumulative probability of survival in the DCM patients with ES and in those without ES. As demonstrated, there was a significant difference in the survival between the 2 groups (P<0.0001) and the cumulative mortality for the DCM patients with ES after 60 months was 59%. Table 2 shows the baseline characteristics of the subjects with and without ES, and the result of univariate and multivariate analysis. Using a univariate Cox proportional analysis, the NYHA classification at the time of the ICD implantation, history of any previous heart failure, history of AF before ICD implantation, monomorphic VT as index arrhythmia and the parameters on SAECG including LAS40, RMS40 and TQRSD showed the significant association with ES. The correlation between RMS40 and LAS40 was so strong that we were not able to include these 2 parameters in the multivariate analysis simultaneously. When we included LAS40 in the multivariate analysis, a history of AF before ICD implantation and a longer duration of LAS40 remained (P= 0.021 and 0.0049, respectively), and when we included RMS40 in the multivariate analysis, a history of AF before ICD implantation and a lower value of RMS40 remained as the significant predictors of ES occurrence (P=0.015 and 0.001, respectively), after adjustment for age, sex, LVDd and LVEF. No independent significant relationships were observed between NYHA classification at the time of the ICD implantation, history of any previous heart failure, monomorphic VT as index arrhythmia or value of TQRSD and the occurrence of ES.
Risk Factors for ES
Predictors of ES
Using a sensitivity-specificity analysis utilizing a receiver operating characteristic curve, the cut-off value of LAS40 and RMS40 was set at 56 ms and 11.7 μV to optimize the capability to predict ES. In cases with a cut-off value of LAS40 setting at 56 ms and RMS40 at 11.7 μV, using LAS40 predicted ES with a sensitivity of 94% and specificity of 74%. The areas under the curve of LAS40 at 56 ms was slightly larger than that of RMS40 at 11.7 μV (0.87 vs 0.84, respectively). The Kaplan-Meier curves of the freedom from ES event between the group with or without LAS40 ≥56 ms are illustrated in Figure 2 . The DCM patients with LAS40 ≥56 ms had a significantly higher risk of ES occurrence compared with those with LAS40 <56 ms (P<0.0001). The Kaplan-Meier curves of the freedom from ES event between the group with or without RMS40 ≤11.7 μV are shown in Figure 3 . The DCM patients with RMS40 ≤11.7 μV had a significantly higher risk of ES occurrence compared with those with RMS40 >11.7 μV (P<0.0001). Furthermore, the Kaplan-Meier curves of the freedom from ES event between the groups with and without a history of AF before ICD implantation showed that the DCM patients with a history of AF before ICD implantation had a significantly higher risk of ES occurrence compared with those without a history of AF before ICD implantation (P<0.0001) (Figure 4) . Atrial fibrillation plus 2 of the following parameters could significantly predict the occurrence of ES: SAECG, LAS40 ≥56 ms or RMS40 ≤11.7 μV. As Figure 5 shows, when using the combination of these independent predictors (AF and LAS40 ≥56 ms, or AF and RMS40 ≤11.7 μV), the study population could be stratified into 3 groups according to the risk of ES before the implantation.
Discussion
The main finding of our study was that both the quantitative value of the SAECG, especially the value of LAS40, RMS40 and a history of AF before ICD implantation could independently predict the occurrence of ES.
SAECG as a Predictor of ES
Regarding the SAECG, longer LAS40 and lower RMS40 remained a significant index for predicting the occurrence of ES by multivariate analysis, although all 3 parameters on the SAECG; longer LAS40, lower RMS40 and longer TQRSD, were significant by univariate analysis. The risk of ES increased by 40% for each additional 10 ms increase in the value . The cumulative probability of freedom from electrical storm (ES) events in dilated cardiomyopathy (DCM) patients with or without a history of atrial fibrillation (AF) before an implantable cardioverter defibrillator (ICD) implantation. The DCM patients with a history of AF before ICD implantation had a significantly higher risk of ES occurrence compared with those without a history of AF before ICD implantation (P<0.0001).
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of LAS40 (HR 1.4/10 ms increase, 95% confidence interval (CI) 1.1-2.1; P=0.0049). The optimized cut-off value of LAS40 determined from the receiver operating characteristic curve for differentiating the patients with ES from those without ES was 56 ms, which gave a sensitivity of 94%, specificity of 74%, positive predictive value of 65% and negative predictive value of 96%. In contrast, the risk of ES decreased by 12% for each additional 1 μV increase in the value of RMS40 (HR 0.88/1 μV, 95%CI 0.77-0.96; P=0.001). The optimized cut-off value of RMS40 determined from the receiver operating characteristic curve for differentiating the patients with ES from those without ES was 11.7 μV, which gave a sensitivity of 100%, specificity of 71%, positive predictive value of 61% and negative predictive value of 100%. We used the optimized cutoff value of LAS40 as 56 ms and RMS40 as 11.7 μV to stratify the risk of ES. However, the cut-off value of LAS40 was usually set at 38 ms and RMS40 at 20 μV. We also evaluated the significance of the SAECG for predicting the occurrence of ES by using the cut-off value of LAS40 at 38 ms and RMS40 at 20 μV, and it was possible to differentiate the patients with ES from those without ES by using these classical values as well.
Although the significance of the SAECG as a predictor of ES has never been reported thus far, there have been several reports that have indicated the significance of the SAECG as a predictor of ventricular tachyarrhythmias or the prognosis in DCM patients. 10-16 Goedel-Meinen et al reported that an abnormal SAECG was an independent indicator for sudden cardiac death (3.7-fold risk), the total cardiac mortality (2.1fold risk) and any cardiac events (2-fold risk) in patients with DCM using a multivariate analysis. 12 Mancini et al showed the effectiveness of SAECG as an independent predictor of end points including death, urgent transplant and VT in patients with non-ischemic congestive cardiomyopathy and relative risk estimate (actually an odds ratio) for abnormal vs normal SAECG was 16.7:1 for these events in this report. 10 The SAECG is a modality for assessing the existence of ventricular late potentials, which indicate an arrhythmic substrate, especially depolarization abnormalities, leading to sustained ventricular tachyarrhythmias. In general, ventricular late potentials may be defined as low-amplitude fractionated activity appearing at the end of QRS and extending into the ST-segment. Fragmented electrocardiograms are thought to be found when myocardial fibers are separated by connective tissue. Moreover, a close correlation between the presence of continuous fractionated electrical activity and the perpetuation of VT has been demonstrated. 17, 18 The extent of the myocardial fibrosis also appears to be correlated with an abnormal SAECG. Yamada et al reported that patients with biopsy-proven marked fibrosis exhibited a longer TQRSD and lower LAS40 than did the patients with less fibrosis, although those patients had no differences in the left ventricular end-diastolic dimension and ejection fraction. 19 This relation was also confirmed in a study by Konta et al, which demonstrated that patients with DCM had abnormal thallium perfusion images. 20 These principles could support the theory that the late potentials could contribute to the maintenance of the electrical instability, thus increasing the possibility of the occurrence of ES. The myocardium in the patients with ES would be more damaged with more severe late potentials, and thus the conventional cut-off value (TQRSD >120 ms, RMS40 <20 μV and LAS40 >38 ms) would not be adequate for specifically predicting ES. [21] [22] [23] [24] [25] A History of AF Before ICD Implantation as a Predictor of ES Our study showed that a history of AF before ICD implantation was a strong independent predictor of the occurrence of ES (HR 2.3, 95%CI 1.2-5.0; P=0.013). Although there have been no reports assessing the significance of a history of AF before ICD implantation as a predictor of ES thus far, its significance as a predictor of ventricular arrhythmias has been reported in previous studies. 26-28 Moreover, Grimm et al reported that AF, the LVEF and a history of VT/VF before an ICD implantation were the predictors for an appropriate ICD intervention in DCM patients during 36 months of follow-up. 29 Because ES is considered to be one of the most severe cases of ventricular tachyarrhythmias, it is not unreasonable that AF could be one of the predictors of ES as the result of our study. There are several possible explanations for the association between a history of AF before ICD implantation and ventricular tachyarrhythmias including ES. First, a rapid ventricular rate during AF will directly reduce the ventricular refractoriness and, moreover, the irregular rhythm during both paroxysmal and persistent AF leads to a high incidence of short-long-short sequences, which could have a pro-arrhythmic effect. Second, AF decreases the cardiac output and increases the filling pressure through the loss of an atrial effective contraction and decreased diastolic time, which could affect the electrophysiological properties. Third, AF could trigger ischemia, through a tachycardia, also leading to a reduction in the cardiac output and increasing the left ventricular filling pressure or directly changing the electrophysiological properties of the ventricles. 27,30- 34 To the best of our knowledge, the only study that referred to ES with DCM patients was published by Bansch et al. 1 They reported that the presence of NYHA III heart failure before an ICD implantation, low LVEF (<40%), a history of monomorphic VT or inducibility of monomorphic VT, especially that with a superior axis, were the best predictors of ES in patients with DCM. 1 Unlike that study, the LVEF did not remain as a significant risk factor in the present study. The baseline LVEF was tightly distributed at much lower levels between the 2 groups with and without ES in our study, so that the difference in the LVEF between each patient could fall into obscurity. Although heart failure and monomorphic VT remained as significant predictors of ES by univariate analysis, they did not remain so by multivariate analysis. The difference in the study population, the severity of any underlying disease or the definition of ES could be part of the reason for the discrepancies with previous studies. 1, 8, 35, 36 Potential Approaches to Prevent ES Potential approaches were considered to prevent ES. First, recent reports revealed that novel empiric ablation techniques for substrate modification and prevention of VT/VF could reduce the ICD therapy, 37,38 and cardiac resynchronization therapy could reduce the incidence of VT due to reverse remodeling. 39, 40 Pulmonary vein isolation may be 1 of the options to prevent ES by suppression of AF. 41
Study Limitations
First, the retrospective observational design was a major limitation of our study. Furthermore, the accurate classification of shocks as being appropriate or inappropriate remains a problem, especially for patients with a single-chamber ICD. Because patients with a history of AF before ICD implantation were more likely to have single-chamber ICDs, there may have been more false positive events in the history of the AF group. However, the ICD electrograms were carefully examined by 2 expert electrophysiologists blindly to confirm that inappropriate therapy was not a trigger of these ESs and to determine the appropriateness of the ICD shocks.
Second, because the number of patients in the study group was small, the statistical power of the patient group analyses may therefore be limited. However, the study group was relatively homogeneous because all consecutive secondary prevention patients were included.
Third, cardiac resynchronization therapy with a defibrillator function should be used in our study population, which would reduce the occurrence of ES at this moment. However, cardiac resynchronization therapy with a defibrillator function was not available in Japan back then.
Conclusion
ESs occur frequently in ICD patients with DCM. The major predictors of ES were a longer LAS40, a lower RMS40 and a history of AF before ICD implantation. The combination of these indices could effectively stratify the risk of ES prior to the ICD implantation.
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